ARTICLE | Company News
Graffinity in Aventis deal
May 31, 2001 7:00 AM UTC
Chemical proteomics play Graffinity (Heidelberg, Germany) will use its chemical microarray-based discovery technology to identify lead structures for Aventis Pharma (AVE). ...